MDXG MiMedx Group, Inc.

NASDAQ
$4.67

MiMedx Group, Inc. (MDXG) is expected to report earnings on November 2, 2026, after the market close. The stock has had a Post-Earnings Announcement Drift (PEAD) of +19.7% since its last earnings release on July 29, 2026.

MiMedx Group Reported Earnings
Wednesday, July 29, 2026 · 4:07 PM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 2
Monday · 4:05 PM ET
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $4.43

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About MiMedx Group, Inc.

MiMedx Group Inc is a developer, manufacturer and marketer of patent-protected regenerative biomaterial products and bioimplants processed from human amniotic membrane.

Sector

Healthcare

Industry

Biotechnology

Held By 2 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.